A Phase I, 2-Part, Single-dose, Placebo and Active-Controlled, Dose-ranging, Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Tiotropium bromide (Primary) ; Bronchodilators
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pulmatrix
- 23 Sep 2015 Results published in a Pulmatrix media release.
- 23 Sep 2015 Results of this trial will be presented at the 2015 European Respiratory Society Congress, according to a Pulmatrix media release.
- 17 Mar 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.